Gene Variation of Endoplasmic Reticulum Aminopeptidase 1 and Risk of Incident Type 2 Diabetes Mellitus amongst 22,718 Initially Healthy Women

Publisher： Bentham Science Publishers

ISSN： 2212-7070

Source： Clinical Immunology, Endocrine & Metabolic Drugs, Vol.4, Iss.1, 2018-02, pp. : 70-74

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preventing Type 1 Diabetes Mellitus: The Promise of Gene Therapy

By Efrat S.

American Journal of PharmacoGenomics, Vol. 2, Iss. 2, 2002-01 ,pp. : 129-134

Adis International

Access to resources Recommend Favorite

Safety and Tolerability of Acarbose in the Treatment of Type 1 and Type 2 Diabetes Mellitus

By Neuser Dieter

Clinical Drug Investigation, Vol. 25, Iss. 9, 2005-01 ,pp. : 579-587

Adis International

Access to resources Recommend Favorite

A Risk-Benefit Assessment of Metformin in Type 2 Diabetes Mellitus

By Howlett H.C.S.

Drug Safety, Vol. 20, Iss. 6, 1999-06 ,pp. : 489-503

Adis International

Access to resources Recommend Favorite

Metformin may reduce the risk of cancer in patients with type 2 diabetes mellitus

Inpharma, Vol. 1, Iss. 1491, 2005-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Benefit-Risk Assessment of Exenatide in the Therapy of Type 2 Diabetes Mellitus

By Gallwitz Baptist

Drug Safety, Vol. 33, Iss. 2, 2010-02 ,pp. : 87-100

Adis International

Access to resources Recommend Favorite